Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cecilia, Trinks"'
Autor:
Karolina Engström, Farkas Vánky, Malin Rehnberg, Cecilia Trinks, Jon Jonasson, Anna Green, Cecilia Gunnarsson
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 4, Pp n/a-n/a (2020)
Abstract Background Pathogenic variants in the SMAD3 gene affecting the TGF‐β/SMAD3 signaling pathway with aortic vessel involvement cause Loeys‐Dietz syndrome 3, also known as aneurysms–osteoarthritis syndrome. Methods Description of clinical
Externí odkaz:
https://doaj.org/article/c1d3e3af07a44958ab05b8eaf7f1c46c
Autor:
Karolina Engström, Farkas Vánky, Malin Rehnberg, Cecilia Trinks, Jon Jonasson, Anna Green, Cecilia Gunnarsson
Publikováno v:
Molecular Genetics & Genomic Medicine. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66c26e21abb18d1d79bf4a1779387b78
https://doi.org/10.1002/mgg3.1270
https://doi.org/10.1002/mgg3.1270
Autor:
Cecilia Gunnarsson, Anna Gréen, Jon Jonasson, Cecilia Trinks, Jan-Erik Karlsson, Antheia Kissopoulou
Publikováno v:
ESC Heart Failure. 5:716-723
Hypertrophic cardiomyopathy (HCM) is a primary autosomal-dominant disorder of the myocardium with variable expressivity and penetrance. Occasionally, homozygous sarcomere genetic variants emerge while genotyping HCM patients. In these cases, a more s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c97f8b7181fb2e61021c969787432dd7
https://doi.org/10.1002/ehf2.12288
https://doi.org/10.1002/ehf2.12288
Autor:
Birgitta Holmlund, Salumeh Bastami, Srinivas Uppugunduri, Thomas M. Walz, Cecilia Trinks, Johan Ahlner, Cecilia Norling
Publikováno v:
Acta Oncologica. 52:1022-1033
Most patients with advanced cancer experience severe pain and are often treated with opiates. Cancer patients are especially susceptible to opportunistic infections due to treatment with immunosuppressive and cytostatic drugs. Since opiates have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53fef28f2cea851328896b869c1093bc
https://doi.org/10.3109/0284186x.2012.737932
https://doi.org/10.3109/0284186x.2012.737932
Autor:
Henrik Gréen, Thomas M. Walz, Anna-Lotta Hallbeck, Olle Stål, Avni Abdiu, Emelie Severinsson, Cecilia Trinks
Publikováno v:
Biochemical and biophysical research communications. 414(3)
The ErbB receptor family has been suggested to constitute a therapeutic target for tumor-specific treatment of malignant melanoma. Here we investigate the effect of the pan-ErbB tyrosine kinase inhibitor canertinib on cell growth and survival in huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500aadc5340e4dd704d30341e897aa10
https://pubmed.ncbi.nlm.nih.gov/21982771
https://pubmed.ncbi.nlm.nih.gov/21982771
Autor:
Amanda, Nordigården, Jenny, Zetterblad, Cecilia, Trinks, Henrik, Gréen, Pernilla, Eliasson, Pia, Druid, Kourosh, Lotfi, Lars, Rönnstrand, Thomas M, Walz, Jan-Ingvar, Jönsson
Publikováno v:
British journal of haematology. 155(2)
Recent findings have indicated that tyrosine kinase inhibitors (TKIs) targeting the ERBB receptor family display anti-leukaemic effects, despite the lack of receptor expression on human leukaemic cells. The occurrence of activating mutations in the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae1f2b3ec42e4e2db3c6ed70985e5989
https://pubmed.ncbi.nlm.nih.gov/21848891
https://pubmed.ncbi.nlm.nih.gov/21848891
Publikováno v:
Biochemical and biophysical research communications. 393(1)
Epidermal growth factor (EGF) receptor tyrosine kinase inhibitors have recently been shown to display anti-neoplastic effects in human malignant myeloid cells. Our study was initiated in order to determine the effect of the pan-ErbB receptor tyrosine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37de16aae1334c9e6b046642a165ae59
https://pubmed.ncbi.nlm.nih.gov/20096663
https://pubmed.ncbi.nlm.nih.gov/20096663
Autor:
Avni Abdiu, Thomas Walz, Lena K. Thunell, Anna-Lotta Hallbeck, Emelie A. Djerf, Cecilia Trinks
Publikováno v:
Melanoma research. 19(3)
Members of the epidermal growth factor (EGF) family of structurally related tyrosine kinase receptors, known as the ErbB receptors (EGFR/ErbB1/HER1, ErbB2/HER2/neu, ErbB3/HER3 and ErbB4/HER4) and their respective ligands, have been suggested to be in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3cd776366e87bb0435ce5e36f47d993
https://pubmed.ncbi.nlm.nih.gov/19434003
https://pubmed.ncbi.nlm.nih.gov/19434003
Autor:
Sven, Hammarstrom, Cecilia, Trinks, Jane, Wigren, Sailesh, Surapureddi, Matts, Soderstrom, Christopher K, Glass
Publikováno v:
Advances in experimental medicine and biology. 507
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::889b153027a586522974a8493fe47b18
https://pubmed.ncbi.nlm.nih.gov/12664608
https://pubmed.ncbi.nlm.nih.gov/12664608
Autor:
Jane Wigren, Christopher K. Glass, Cecilia Trinks, Sven Hammarström, Mats Söderström, Sailesh Surapureddi
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461349600
Prostaglandin D2 (PGD2) is a major arachidonic acid metabolite in mast cells, megakaryoblastic CMK cells and antigen presenting cells, for example various types of macrophages. It induces pulmonary vasoconstriction and bronchoconstriction. Increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dec20bdc4ad678c22e334ccc6fc11814
https://doi.org/10.1007/978-1-4615-0193-0_53
https://doi.org/10.1007/978-1-4615-0193-0_53
